A. Saha

发表

Immunogenicity of a Killed Bivalent (O1 and O139) Whole Cell Oral Cholera Vaccine, Shanchol, in Haiti

S. Calderwood, Jason B. Harris, R. Charles, 2014, PLoS neglected tropical diseases.

Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age.

F. Qadri, A. Cravioto, A. Saha, 2011, Vaccine.

Economic Evaluation Of Dairy Farming Systems In Haryana

A. Saha, 2003 .

Organization and implementation of an oral cholera vaccination campaign in an endemic urban setting in Dhaka, Bangladesh

F. Qadri, A. Saha, J. Clemens, 2019, Global health action.

Socioeconomic risk factors for cholera in different transmission settings: An analysis of the data of a cluster randomized trial in Bangladesh.

A. Hayen, F. Qadri, A. Saha, 2017, Vaccine.

INTEGRATION OF SINGLE EXPONENTIAL SMOOTHING WITH STATE SPACE FORMULATION

A. Saha, 2016 .

Cost of illness for cholera in a high risk urban area in Bangladesh: an analysis from household perspective

A. Sarker, F. Qadri, A. Saha, 2013, BMC Infectious Diseases.

A decentralised point-of-care testing model to address inequities in the COVID-19 response

R. Guy, A. Saha, C. Watts, 2020, The Lancet Infectious Diseases.

Seroprevalence of hepatitis B antibodies among international and domestic university students

H. Seale, N. Zwar, A. Saha, 2021, Journal of viral hepatitis.

Improving immunization approaches to cholera

C. Macintyre, A. Hayen, F. Qadri, 2017, Expert review of vaccines.

Evaluation of a probiotics, Bifidobacterium breve BBG-01, for enhancement of immunogenicity of an oral inactivated cholera vaccine and safety: a randomized, double-blind, placebo-controlled trial in Bangladeshi children under 5 years of age.

F. Matsuda, F. Qadri, A. Cravioto, 2011, Vaccine.

Socioeconomic drivers of vaccine uptake: An analysis of the data of a geographically defined cluster randomized cholera vaccine trial in Bangladesh☆

C. Macintyre, A. Hayen, F. Qadri, 2018, Vaccine.

The oral cholera vaccine Shanchol™ when stored at elevated temperatures maintains the safety and immunogenicity profile in Bangladeshi participants.

F. Qadri, A. Cravioto, A. Saha, 2016, Vaccine.

Coverage and acceptability of cholera vaccine among high-risk population of urban Dhaka, Bangladesh.

F. Qadri, A. Saha, J. Clemens, 2014, Vaccine.

Immune Responses to the O-Specific Polysaccharide Antigen in Children Who Received a Killed Oral Cholera Vaccine Compared to Responses following Natural Cholera Infection in Bangladesh

T. Sultana, S. Calderwood, R. Charles, 2013, Clinical and Vaccine Immunology.

Memory B Cell and Other Immune Responses in Children Receiving Two Doses of an Oral Killed Cholera Vaccine Compared to Responses following Natural Cholera Infection in Bangladesh

M. Riyadh, S. Calderwood, R. Charles, 2012, Clinical and Vaccine Immunology.

Feasibility, coverage and cost of oral cholera vaccination conducted by icddr,b using the existing national immunization service delivery mechanism in rural setting Keraniganj, Bangladesh

A. Saha, F. Chowdhury, I. A. Khan, 2018, Human vaccines & immunotherapeutics.

Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh.

F. Qadri, A. Cravioto, A. Saha, 2013, Vaccine.

Antigen-Specific Memory T Cell Responses after Vaccination with an Oral Killed Cholera Vaccine in Bangladeshi Children and Comparison to Responses in Patients with Naturally Acquired Cholera

M. Arifuzzaman, S. Calderwood, R. Charles, 2012, Clinical and Vaccine Immunology.

Salmonella enterica Serovar Typhi-Specific Immunoglobulin A Antibody Responses in Plasma and Antibody in Lymphocyte Supernatant Specimens in Bangladeshi Patients with Suspected Typhoid Fever

W. A. Brooks, S. Calderwood, R. Charles, 2009, Clinical and Vaccine Immunology.

Knowledge of, attitudes toward, and preventive practices relating to cholera and oral cholera vaccine among urban high-risk groups: findings of a cross-sectional study in Dhaka, Bangladesh

J. Uddin, F. Qadri, A. Cravioto, 2013, BMC Public Health.

A Review of Milk Production in India with Particular Emphasis on Small-Scale Producers

A. Saha, T. Hemme, O. Garcia, 2003 .

Disease Burden Due to Enterotoxigenic Escherichia coli in the First 2 Years of Life in an Urban Community in Bangladesh

F. Qadri, A. Saha, Y. Begum, 2007, Infection and Immunity.

Effect of awareness, quarantine and vaccination as control strategies on COVID-19 with Co-morbidity and Re-infection

A. Saha, S. Saha, C. Podder, 2022, Infectious Disease Modelling.

Vaccine specific immune response to an inactivated oral cholera vaccine and EPI vaccines in a high and low arsenic area in Bangladeshi children.

F. Qadri, A. Saha, M. Chowdhury, 2013, Vaccine.

Zinc influences innate immune responses in children with enterotoxigenic Escherichia coli-induced diarrhea.

F. Qadri, A. Saha, M. Chowdhury, 2010, The Journal of nutrition.

Evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh.

D. Sack, F. Qadri, A. Saha, 2014, Vaccine.

Kinetics of antibody-secreting cell and fecal IgA responses after oral cholera vaccination in different age groups in a cholera endemic country.

F. Qadri, A. Saha, A. Svennerholm, 2017, Vaccine.

Seasonal correlation of diseases and ethnomedicinal plants used by tribals of Asansol subdivision (Burdwan district) of West Bengal, India.

A. Saha, S. C. Sahu, 2012 .

Gut Microbiota and Development of Vibrio cholerae-Specific Long-Term Memory B Cells in Adults after Whole-Cell Killed Oral Cholera Vaccine

A. Weil, R. LaRocque, F. Qadri, 2021, Infection and immunity.

Response on letter by Arya et al.: "evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh.".

D. Sack, F. Qadri, A. Saha, 2014, Vaccine.

Infection by Helicobacter Pylori in Bangladeshi Children From Birth to Two Years: Relation to Blood Group, Nutritional Status, and Seasonality

F. Qadri, A. Saha, A. Svennerholm, 2009, The Pediatric infectious disease journal.

Immune responses to Helicobacter pylori infection in Bangladeshi children during their first two years of life and the association between maternal antibodies and onset of infection.

F. Qadri, A. Saha, A. Svennerholm, 2010, The Journal of infectious diseases.

Safety of a bivalent, killed, whole-cell oral cholera vaccine in pregnant women in Bangladesh: evidence from a randomized placebo-controlled trial

F. Qadri, A. Saha, J. Clemens, 2019, BMC Infectious Diseases.

Diarrheal Illness and Healthcare Seeking Behavior among a Population at High Risk for Diarrhea in Dhaka, Bangladesh

F. Qadri, A. Cravioto, A. Saha, 2015, PloS one.

Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery

Philip R. O. Payne, Steven M. Johnson, David A. Eichmann, 2022, Annals of Surgical Oncology.

Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial

M. Asaduzzaman, F. Begum, F. Qadri, 2015, The Lancet.

Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants.

D. Sack, S. Faruque, J. Mekalanos, 2007, Vaccine.

Estimating the cost of cholera-vaccine delivery from the societal point of view: A case of introduction of cholera vaccine in Bangladesh.

A. Sarker, F. Qadri, A. Cravioto, 2015, Vaccine.

Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial.

M. Asaduzzaman, F. Qadri, A. Cravioto, 2018, The Lancet. Infectious diseases.

Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in Bangladesh.

M. Asaduzzaman, F. Qadri, A. Cravioto, 2016, The New England journal of medicine.

Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh.

D. Sack, S. Faruque, J. Mekalanos, 2005, The Journal of infectious diseases.

Biomarkers of Environmental Enteropathy are Positively Associated with Immune Responses to an Oral Cholera Vaccine in Bangladeshi Children

S. Calderwood, D. Leung, F. Qadri, 2016, PLoS neglected tropical diseases.

The Economics of Milk Production in Orissa, India, with particular Emphasis on Small-scale Producers

A. Saha, T. Hemme, O. Garcia, 2004 .

Technical efficiency of dairy farms in developing countries: a case study of Haryana state, India

D. K. Jain, A. Saha, 2004 .

The added benefit of zinc supplementation after zinc treatment of acute childhood diarrhoea: a randomized, double‐blind field trial

F. Qadri, A. Saha, M. Chowdhury, 2010, Tropical medicine & international health : TM & IH.

A hybrid spatio-temporal modelling: an application to space-time rainfall forecasting

Mrinmoy Ray, Santosha Rathod, K. N. Singh, 2020, Theoretical and Applied Climatology.

Competitiveness of milk production in main milk producing countries

A. Saha, T. Hemme, 2005 .

Ethnobotanical Survey of Asansol (Burdwan District), West Bengal, India

A. Saha, 2011 .

Class and changing urban life styles in Narayanganj: A sociological study

A. Saha, 2015 .

Causes of death through verbal autopsy: findings from a sub-study of single dose oral cholera vaccination in urban Dhaka, Bangladesh

F. Qadri, A. Saha, J. Clemens, 2022, Journal of Global Health Reports.

Immune Responses to Helicobacter pylori Infection in Bangladeshi Children during their First Two Years of Life and the Association between Maternal Antibodies and Onset of Infection

F. Qadri, A. Saha, A. Svennerholm, 2010 .

killed oral cholera vaccine compared to responses following natural cholera infection in

S. Calderwood, R. Charles, D. Leung, 2012 .

Biomarkers of Environmental Enteropathy are Positively Associated with Immune Responses to an Oral Cholera Vaccine in Bangladeshi Children

S. Calderwood, D. Leung, F. Qadri, 2016, PLoS neglected tropical diseases.

Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age.

F. Qadri, A. Cravioto, A. Saha, 2011, Vaccine.